These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7693989)

  • 41. [Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma].
    Zhao J; Hu J; Cai J
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):389-92. PubMed ID: 11810769
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma proteasome level is a reliable early marker of malignant transformation of liver cirrhosis.
    Henry L; Lavabre-Bertrand T; Vercambre L; Ramos J; Carillo S; Guiraud I; Pouderoux P; Bismuth M; Valats JC; Demattei C; Duny Y; Chaze I; Funakoshi N; Bureau JP; Daurès JP; Blanc P
    Gut; 2009 Jun; 58(6):833-8. PubMed ID: 19201777
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
    Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
    J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical feminisation and sex hormone concentrations in Nigerian men with cirrhosis with and without hepatocellular carcinoma.
    Olubuyide IO; Ola OS
    Br J Clin Pract; 1994; 48(2):70-2. PubMed ID: 8024993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical evaluation of erythrocytosis in patients with hepatocellular carcinoma.
    Hwang SJ; Lee SD; Wu JC; Chang CF; Lu CL; Tsay SH; Lo KJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 May; 53(5):262-9. PubMed ID: 7518732
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases.
    Shiota G; Umeki K; Okano J; Kawasaki H
    J Med; 1995; 26(5-6):295-308. PubMed ID: 8721905
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Erythropoietin in hepatocellular carcinoma].
    Malaguarnera M; Bentivegna P; Di Fazio I; Laurino A; Romano M; Trovato BA
    Bull Cancer; 1996 Dec; 83(12):977-80. PubMed ID: 9116377
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The significance of serum levels of adiponectin, leptin, and hyaluronic acid in hepatocellular carcinoma of cirrhotic and noncirrhotic patients.
    Sadik NA; Ahmed A; Ahmed S
    Hum Exp Toxicol; 2012 Apr; 31(4):311-21. PubMed ID: 22249387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enzyme-linked immunosorbent assay for alpha-fetoprotein in human serum.
    Chui SH; Yow CM; Lam CW; Wan KC; Lewis WH
    Med Lab Sci; 1989 Oct; 46(4):305-8. PubMed ID: 2482399
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunoreactive erythropoietin in the anemia of non-renal chronic diseases.
    Jelkmann W; Fandrey J; Wiedemann G
    Biomed Biochim Acta; 1990; 49(2-3):S265-70. PubMed ID: 2167083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum erythropoietin concentrations in patients with hepatocellular carcinoma.
    Kew MC; Fisher JW
    Cancer; 1986 Dec; 58(11):2485-8. PubMed ID: 2429757
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum transforming growth factor alpha level as a marker of hepatocellular carcinoma complicating cirrhosis.
    Tomiya T; Fujiwara K
    Cancer; 1996 Mar; 77(6):1056-60. PubMed ID: 8635123
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IL-6 -174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma.
    Giannitrapani L; Soresi M; Giacalone A; Campagna ME; Marasà M; Cervello M; Marasà S; Montalto G
    OMICS; 2011 Mar; 15(3):183-6. PubMed ID: 21329460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduced serum levels of immunoreactive erythropoietin in patients with cirrhosis and chronic anemia.
    Siciliano M; Tomasello D; Milani A; Ricerca BM; Storti S; Rossi L
    Hepatology; 1995 Oct; 22(4 Pt 1):1132-5. PubMed ID: 7557862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases.
    Shirai Y; Kawata S; Tamura S; Ito N; Tsushima H; Takaishi K; Kiso S; Matsuzawa Y
    Cancer; 1994 May; 73(9):2275-9. PubMed ID: 7513247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peptide hormones in liver cirrhosis and hepatocellular carcinoma.
    Scheuer A; Grün R; Lehmann FG
    Oncodev Biol Med; 1981; 2(1-2):1-10. PubMed ID: 6272236
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevated renin levels in patients with liver cirrhosis and hepatocellular carcinoma.
    Lotfy M; El-Kenawy Ael-M; Abdel-Aziz MM; El-Kady I; Talaat A
    Asian Pac J Cancer Prev; 2010; 11(5):1263-6. PubMed ID: 21198274
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Erythropoiesis, erythropoietin and blood lead levels.
    Liberatori R; Romeo R; Porcelli B; Barabesi L; Sartorelli P
    G Ital Med Lav Ergon; 2011; 33(1):37-40. PubMed ID: 21417137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum factor from patients with cirrhosis and hepatocellular carcinoma enhances production of prostaglandin E2 by U937 cells.
    Iwamoto H; Sakamoto S; Nawata H
    Hepatology; 1991 Dec; 14(6):1123-8. PubMed ID: 1660019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.